Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All alkalinization studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchAlkalinizationAlkalinization (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Hospitalization 86% Improvement Relative Risk Viral load density, day 7 62% Viral load density, day 3 43% Alkalinization  Yilmaz et al.  EARLY TREATMENT  RCT Is early treatment with alkalinization beneficial for COVID-19? RCT 60 patients in Turkey (July - September 2020) Lower hospitalization with alkalinization (not stat. sig., p=0.24) c19early.org Yilmaz et al., Laryngoscope Investigat.., Nov 2021 Favors alkalinization Favors control

Effects of hypertonic alkaline nasal irrigation on COVID‐19

Yilmaz et al., Laryngoscope Investigative Otolaryngology, doi:10.1002/lio2.686
Nov 2021  
  Post
  Facebook
Share
  Source   PDF   All   Meta
30th treatment shown to reduce risk in December 2021
 
*, now known with p = 0.0000043 from 11 studies.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,000+ studies for 60+ treatments. c19early.org
RCT 60 outpatients with mild COVID-19 showing improved viral clearance with hypertonic alkaline (pH 9.3) nasal irrigation. All patients received HCQ. The nasal irrigation group had no hospitalizations, while 3 patients in the control group required hospitalization, associated with viral load increase at day 3.
Targeted administration to the respiratory tract provides treatment directly to the typical source of initial SARS-CoV-2 infection and replication, and allows for rapid onset of action and reduced systemic side effects.
risk of hospitalization, 85.7% lower, RR 0.14, p = 0.24, treatment 0 of 30 (0.0%), control 3 of 30 (10.0%), NNT 10.0, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm).
relative viral load density, 62.0% better, RR 0.38, p = 0.87, treatment median 15.0 IQR 43.0 n=30, control median 39.51 IQR 1085.1 n=30, day 7.
relative viral load density, 42.9% better, RR 0.57, p = 0.95, treatment median 1747.0 IQR 5863.5 n=30, control median 3058.0 IQR 145568.9 n=30, day 3.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Yilmaz et al., 19 Nov 2021, Single Blind Randomized Controlled Trial, Turkey, peer-reviewed, 8 authors, study period July 2020 - September 2020. Contact: yetkin.yilmaz@iuc.edu.tr.
This PaperAlkalinizationAll
Effects of hypertonic alkaline nasal irrigation on COVID‐19
Yetkin Zeki Yilmaz, Begum Bahar Yilmaz, Yusuf Emre Ozdemir, Bekir Sami Kocazeybek, MD Ridvan Karaali, Doğan Çakan, Hasan Ahmet Ozdogan, Aysegul Batioglu‐karaaltin
Laryngoscope Investigative Otolaryngology, doi:10.1002/lio2.686
Objective: The causative agent of COVID-19 is a novel member of coronaviridaes, SARS-CoV-2. It has been reported that the spike (S) protein of SARS-CoV-2 is responsible of infectivity. The S protein is demonstrated to be inactivated under environmental condition, such as hypertonicity and alkaline pH. The aim of the study was to investigate the effect of hypertonic alkaline nasal irrigation (HANI) on SARS-CoV-2. Methods: Sixty patients divided into two groups. The patients in Group 1 used hydroxychloroquine (HCQ), and the patients in Group 2 used HCQ and HANI. Nasopharyngeal samples were collected at the beginning, on 3rd and 7th day of the PCR test positivity. The nasopharyngeal viral load (NVL) changes analyzed with quantitative PCR. Results: NVL decrease in weekly period was statistically significant for both groups, when the difference between NVL day 0 and 3rd in Group 1 and NVL difference between day 0 and 3rd in Group 2 were compared. The difference between Groups 1 and 2 in terms of NVL change was statistically significant (P < 0.05). Conclusion: We demonstrated a significant decrease in nasopharyngeal SARS-CoV-2 load with HANI solution and suggest that HANI may be promising modality for the COVID-19 treatment.
CONFLICT OF INTEREST Each of the authors has contributed to, read and approved this manuscript. None of the authors has any conflict of interest.
References
Ali, Alharbi, COVID-19: disease, management, treatment, and social impact, Sci Total Environ, doi:info:doi/10.1016/j.scitotenv.2020.138861
Carsana, Sonzogni, Nasr, Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study, Lancet Infect Dis, doi:info:doi/10.1016/S1473-3099(20)30434-5
Cevik, Tate, Lloyd, SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis, Lancet Microbe, doi:info:doi/10.1016/S2666-5247(20)30172-5
Chin, Chu, Perera, Stability of SARS-CoV-2 in different environmental conditions, Lancet Microbe, doi:info:doi/10.1016/S2666-5247(20)30003-3
Dickson, Erb-Downward, Martinez, Huffnagle, The microbiome and the respiratory tract, Annu Rev Physiol, doi:info:doi/10.1146/annurev-physiol-021115-105238
Faul, Erdfelder, Lang, Buchner, G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences, Behav Res Methods, doi:info:doi/10.3758/BF03193146
Gautret, Lagier, Parola, Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, Int J Antimicrob Agents, doi:info:doi/10.1016/j.ijantimicag.2020.105949
Guan, Liang, Zhao, China medical treatment expert group for COVID-19. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis, Eur Respir J, doi:info:doi/10.1183/13993003.00547-2020
Gul, Atakli, Effect of the COVID-19 pandemic on drug compliance and stigmatization in patients with epilepsy, Epilepsy Behav, doi:info:doi/10.1016/j.yebeh.2020.107610
Hou, Okuda, Edwards, SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract, Cell, doi:info:doi/10.1016/j.cell.2020.05.042
Justo, Bueno, Barbosa, Comparison of viral load between saliva and nasopharyngeal swabs for SARS-CoV2: the role of days of symptoms onset on diagnosis, Mem Inst Oswaldo Cruz, doi:info:doi/10.1590/0074-02760210018
Kang, Yang, Hong, Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites, Acta Pharm Sin B, doi:info:doi/10.1016/j.apsb.2020.04.009
Khailany, Safdar, Ozaslan, Genomic characterization of a novel SARS-CoV-2, Gene Rep, doi:info:doi/10.1016/j.genrep.2020.100682
Komissarov, Molodtsov, Ivanova, Hydroxychloroquine has no effect on SARS-CoV-2 load in nasopharynx of patients with mild form of COVID-19, medRxiv, doi:info:doi/10.1101/2020.06.30.20143289
Lamas, Dios, Rodríguez, IS povidone iodine mouthwash effective against SARS-CoV-2? First in vivo tests, Oral Dis, doi:10.1111/odi.13526
Li, Guan, Wu, Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia, N Engl J Med, doi:info:doi/10.1056/NEJMoa2001316
Lisco, Giagulli, Pergola, Tullio, Guastamacchia et al., Covid-19 in man: a very dangerous affair, Endocr Metab Immune Disord Drug Targets, doi:10.2174/1871530321666210101123801
Liu, Yi, Zhang, Lv, Zhu et al., Viral load dynamics in sputum and nasopharyngeal swab in patients with COVID-19, Laryngoscope Investigative Otolaryngology, doi:info:doi/10.1002/lio2.686
Lu, Zhao, Li, Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet, doi:info:doi/10.1016/S0140-6736(20)30251-8
Lund, Scadding, Objective assessment of endoscopic sinus surgery in the management of chronic rhinosinusitis: an update, J Laryngol Otol, doi:info:doi/10.1017/s0022215100128014
Machado, Glaser, Araujo, Hypertonic saline solution inhibits SARS-CoV-2 in vitro assay, bioRxiv, doi:info:doi/10.1101/2020.08.04.235549
Morawska, Cao, Airborne transmission of SARS-CoV-2: the world should face the reality, Environ Int, doi:info:doi/10.1016/j.envint.2020.105730
Porta-Etessam, Núñez-Gil, García, COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (health outcome predictive evaluation for COVID-19) registry, Infection, doi:10.1007/s15010-021-01587-9
Ramalingam, Graham, Dove, Morrice, Sheikh, A pilot, open labelled, randomised controlled trial of hypertonic saline nasal irrigation and gargling for the common cold, Sci Rep, doi:info:doi/10.1038/s41598-018-37703-3
Rey, Lok, Common features of enveloped viruses and implications for immunogen design for next-generation vaccines, Cell, doi:info:doi/10.1016/j.cell.2018.02.054
Sarma, Kaur, Kumar, Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: a systematic review and meta-analysis, J Med Virol, doi:info:doi/10.1002/jmv.25898
Scadding, Lund, Darby, The effect of long-term antibiotic therapy upon ciliary beat frequency in chronic rhinosinusitis, J Laryngol Otol, doi:info:doi/10.1017/s0022215100129159
Shameena, Khan, A comparative study of cost optimization model under parametric and nonparametric approach, J Inf Comput Sci
Singh, Singh, Singh, Misra, Hydroxychloroquine in patients with COVID-19: a systematic review and meta-analysis, Diabetes Metab Syndr, doi:info:doi/10.1016/j.dsx.2020.05.017
Talbot, Herr, Parsons, Mucociliary clearance and buffered hypertonic saline solution, Laryngoscope, doi:info:doi/10.1097/00005537-199704000-00013
Tang, Cao, Han, Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial, BMJ, doi:info:doi/10.1136/bmj.m1849
Tomonaga, Brennwald, Livingstone, Porewater salinity reveals past lake-level changes in Lake Van, the Earth's largest soda lake, Sci Rep, doi:info:doi/10.1038/s41598-017-00371-w
Wilson, Norton, Young, Collins, Airborne transmission of severe acute respiratory syndrome coronavirus-2 to healthcare workers: a narrative review, Anaesthesia, doi:info:doi/10.1111/anae.15093
Wu, Nethery, Sabath, Braun, Dominici, Air pollution and COVID-19 mortality in the United States: strengths and limitations of an ecological regression analysis, Sci Adv, doi:info:doi/10.1126/sciadv.abd4049
Wölfel, Corman, Guggemos, Virological assessment of hospitalized patients with COVID-2019, Nature, doi:info:doi/10.1038/s41586-020-2196-x
Yan, Zhang, Li, Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2, Science, doi:info:doi/10.1126/science.abb2762
Zhang, Lin, Sun, Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science, doi:info:doi/10.1126/science.abb3405
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit